-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vaccinex, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q2 2024.
- Vaccinex, Inc. Depreciation for the quarter ending June 30, 2024 was $25K, a 16.7% decline year-over-year.
- Vaccinex, Inc. Depreciation for the twelve months ending June 30, 2024 was $110K, a 36.4% decline year-over-year.
- Vaccinex, Inc. annual Depreciation for 2023 was $119K, a 42.5% decline from 2022.
- Vaccinex, Inc. annual Depreciation for 2022 was $207K, a 22.5% increase from 2021.
- Vaccinex, Inc. annual Depreciation for 2021 was $169K, a 45% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)